📅Notice of Closed Meeting Change at National Institute on Minority Health
The Department of Health and Human Services announces an amended notice regarding a meeting of the National Institute on Minority Health and Health Disparities. Originally scheduled for April, the meeting will now take place from June 23 to June 27, 2025. The meeting will be closed to the public and will focus on specific health disparities discussions by the Special Emphasis Panel.
Learn More💉FDA Updates on Susceptibility Test Interpretive Criteria Announced
The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of the Agency's annual compilation of notices of updates to the Agency's Susceptibility Test Interpretive Criteria web page. The Agency established the Susceptibility Test Interpretive Criteria web page on December 13, 2017, and since establishment has provided updates to both the format of the web pages and the susceptibility test interpretive criteria identified and recognized by FDA on the web pages. FDA is publishing this notice in accordance with procedures established by the 21st Century Cures Act (Cures Act).
Learn More🧠Amended Notice of Meeting for NIH Center for Scientific Review
This document provides a notice of a scheduled meeting for the Center for Scientific Review's Special Emphasis Panel on Brain Disorders and Related Neurosciences, detailing changes in the meeting's contact person and confirming that it will not be open to the public.
Learn More🏥Amended Notice of Meeting for NIH Special Emphasis Panel
This document provides an amended notice regarding a meeting of the Center for Scientific Review Special Emphasis Panel, focusing on neurobehavior and neuropsychology topics. It details the meeting dates, location, and contact person change, specifying that the meeting is closed to the public.
Learn More🧬Change in Schedule for National Human Genome Research Institute Meeting
The Department of Health and Human Services announced an amended notice regarding the Special Emphasis Panel meeting for the National Human Genome Research Institute. The meeting, now scheduled for April 22, 2025, will be closed to the public and involves a change in the Scientific Review Officer due to staffing adjustments.
Learn More💉NIH Notice on Grant Meeting for Vaccine Development and Research
The Department of Health and Human Services announces a closed meeting by the National Institute of Allergy and Infectious Diseases to review grant applications related to applied immunology and vaccine development. The meeting will evaluate confidential materials and is scheduled for May 2025, conducted via video assistance.
Learn More🏛️Change in NIH Meeting Schedule and Contact Person
The Department of Health and Human Services has amended the notice regarding the schedule and contact person for the Neurobiology of Motivated Behavior Study Section meeting at the National Institutes of Health, emphasizing that the meeting will remain closed to the public.
Learn More🧬NIH National Institute of Biomedical Imaging Meeting Announcement
The National Advisory Council for Biomedical Imaging and Bioengineering will hold a virtual meeting to discuss operational reports and review grant applications. The meeting is open to the public, although portions will be closed to protect confidential commercial and personal information. Interested individuals can file comments or seek accommodations in advance.
Learn More💰NIH Closed Meeting Notice on Grant Applications for Health Research
The Department of Health and Human Services has announced a closed meeting of the National Institute of Diabetes and Digestive and Kidney Diseases to review grant applications. The meeting aims to discuss potentially confidential information, emphasizing the importance of privacy in grant-related deliberations. This session is pivotal for advancing research in health-related fields.
Learn More🧬National Human Genome Research Institute Grant Meeting Notice
The National Human Genome Research Institute announces a closed meeting of the National Advisory Council for Human Genome Research to review and evaluate grant applications. The session, taking place virtually, will address sensitive topics including confidential trade secrets and personal information related to the applications under consideration.
Learn More